Literature DB >> 17405820

Patients' use and perception of medication information leaflets.

Joseph P Nathan1, Tina Zerilli, Lorraine A Cicero, Jack M Rosenberg.   

Abstract

BACKGROUND: Federal law mandates that at least 95% of patients receive useful written information with new medications. Recent data concerning whether patients read such leaflets are lacking.
OBJECTIVES: To evaluate whether patients read non-manufacturer-developed leaflets and assess patients' opinions concerning the understandability and usefulness of these leaflets.
METHODS: Patients were surveyed at 32 community pharmacies in the New York City metropolitan area. The main outcome measures were the percentage of patients who read the leaflet provided with new and refilled medications and the perceived understandability and usefulness of the leaflet. Descriptive statistics were used to analyze the results.
RESULTS: A total of 307 patients were surveyed. For leaflets provided with new medications, 151 (49.2%), 65 (21.2%), 49 (16.0%), and 42 (13.7%) reported reading the leaflets always, often, seldom, or never, respectively. For refilled medications, 64 (21.6%), 41 (13.9%), 78 (26.4%), and 113 (38.2%) of the 296 respondents reported reading the leaflets always, often, seldom, or never, respectively. Of 267 patients who read the leaflets provided with new or refilled prescriptions at least seldom, 258 (96.6%) responded to the question concerning its understandability and 257 (96.3%) responded to the question concerning its usefulness. One hundred forty-five (56.2%), 89 (34.5%), 22 (8.5%), and 2 (0.8%) reported that the leaflet was very easy, somewhat easy, somewhat difficult, and very difficult to understand, respectively, and 164 (63.8%), 90 (35.0%), and 3 (1.2%) reported that the leaflet was very useful, somewhat useful, and not useful, respectively.
CONCLUSIONS: Approximately two-thirds of the patients surveyed reported reading the leaflets provided with new medications at least often. The majority reported the leaflets to be useful and easy to understand. Pharmacists should advocate reading the leaflet and promote it as a useful resource. The leaflet should not replace the pharmacist's obligation to provide verbal counseling.

Entities:  

Mesh:

Year:  2007        PMID: 17405820     DOI: 10.1345/aph.1H686

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  14 in total

1.  Collaborating with youth to inform and develop tools for psychotropic decision making.

Authors:  Andrea Murphy; David Gardner; Stan Kutcher; Simon Davidson; Ian Manion
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-11

2.  A profile of concurrent alcohol and alcohol-interactive prescription drug use in the US population.

Authors:  Jessica J Jalbert; Brian J Quilliam; Kate L Lapane
Journal:  J Gen Intern Med       Date:  2008-09       Impact factor: 5.128

3.  Assessment of patients' knowledge and practices regarding their medication use and risks in Lebanon.

Authors:  Elsy Ramia; Rony M Zeenny; Souheil Hallit; Pascale Salameh
Journal:  Int J Clin Pharm       Date:  2017-07-29

Review 4.  A rapid evidence assessment of the potential risk to the environment presented by active ingredients in the UK's most commonly sold companion animal parasiticides.

Authors:  Clodagh Wells; C M Tilly Collins
Journal:  Environ Sci Pollut Res Int       Date:  2022-04-24       Impact factor: 5.190

5.  Attitudes of consumers and healthcare professionals towards the patient package inserts - a study in Palestine.

Authors:  Rowa' Al-Ramahi; Abdel N Zaid; Na'em Kettana; Waleed Sweileh; Doa' Al-Jabi
Journal:  Pharm Pract (Granada)       Date:  2012-03-31

6.  Pharmacogenetic information for patients on drug labels.

Authors:  Susanne B Haga; Rachel Mills; Jivan Moaddeb
Journal:  Pharmgenomics Pers Med       Date:  2014-10-03

7.  Patients' views on electronic patient information leaflets.

Authors:  Tora Hammar; Anna-Lena Nilsson; Bo Hovstadius
Journal:  Pharm Pract (Granada)       Date:  2016-06-15

8.  Improving the provision of OTC medication information in community pharmacies in Poland.

Authors:  Anna Piecuch; Magdalena Makarewicz-Wujec; Małgorzata Kozłowska-Wojciechowska
Journal:  Int J Clin Pharm       Date:  2016-11-30

9.  Medication understanding and health literacy among patients with multiple chronic conditions: A study conducted in Bangladesh.

Authors:  Fahad Imtiaz Rahman; Farina Aziz; Sumaiya Huque; Sadia Afruz Ether
Journal:  J Public Health Res       Date:  2020-06-18

10.  Development and Evaluation of Patient Information Leaflets (PIL) Usefulness.

Authors:  R Adepu; M K Swamy
Journal:  Indian J Pharm Sci       Date:  2012-03       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.